Antonio Barretta
Sapienza University of Rome
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Antonio Barretta.
Scientific Reports | 2016
Isotta Chimenti; Francesca Pagano; Elena Cavarretta; Francesco Angelini; Mariangela Peruzzi; Antonio Barretta; Ernesto Greco; Elena De Falco; Antonino G.M. Marullo; Sebastiano Sciarretta; Giuseppe Biondi-Zoccai; Giacomo Frati
Β-blockers (BB) are a primary treatment for chronic heart disease (CHD), resulting in prognostic and symptomatic benefits. Cardiac cell therapy represents a promising regenerative treatment and, for autologous cell therapy, the patients clinical history may correlate with the biology of resident progenitors and the quality of the final cell product. This study aimed at uncovering correlations between clinical records of biopsy-donor CHD patients undergoing cardiac surgery and the corresponding yield and phenotype of cardiospheres (CSs) and CS-derived cells (CDCs), which are a clinically relevant population for cell therapy, containing progenitors. We describe a statistically significant association between BB therapy and improved CSs yield and CDCs phenotype. We show that BB-CDCs have a reduced fibrotic-like CD90 + subpopulation, with reduced expression of collagen-I and increased expression of cardiac genes, compared to CDCs from non-BB donors. Moreover BB-CDCs had a distinctive microRNA expression profile, consistent with reduced fibrotic features (miR-21, miR-29a/b/c downregulation), and enhanced regenerative potential (miR-1, miR-133, miR-101 upregulation) compared to non-BB. In vitro adrenergic pharmacological treatments confirmed cytoprotective and anti-fibrotic effects of β1-blocker on CDCs. This study shows anti-fibrotic and pro-commitment effects of BB treatment on endogenous cardiac reparative cells, and suggests adjuvant roles of β-blockers in cell therapy applications.
BioMed Research International | 2015
Antonino G.M. Marullo; Francesco G. Irace; Piergiusto Vitulli; Mariangela Peruzzi; David Rose; Riccardo D’Ascoli; Alessandra Iaccarino; Angelo Pisani; Carlotta De Carlo; Giuseppe Mazzesi; Antonio Barretta; Ernesto Greco
Intraluminal aortic clamping has been achieved until now by means of a sophisticated device consisting of a three-lumen catheter named Endoclamp, which allows at the same time occlusion of the aorta, antegrade delivering of cardioplegia, and venting through the aortic root. This tool has shown important advantages allowing aortic occlusion and perfusate delivering without a direct contact with ascending aorta reducing meanwhile the risk of traumatic and/or iatrogenic injuries. Recently, a new device (Intraclude catheter) with the same characteristics and properties has been proposed and introduced in clinical practice. The aim of this paper is to investigate the differences between Endoclamp and Intraclude catheters and to analyze the advantages advocated by this new device for intraluminal aortic occlusion since it is noticeable as these new technological tools are gaining more and more attractiveness due to their appraised clinical efficacy.
The Annals of Thoracic Surgery | 2016
Antonio Barretta; Ernesto Greco; Massimo Mancone; Gennaro Sardella; Giuseppe Biondi-Zoccai; Mariangela Peruzzi; Antonino G.M. Marullo; Alessandra Piccionetti; Giacomo Frati
itraClip (Abbott Vascular, Santa Clara, CA) imThis unique case of entire MitraClip delivery system entrapment requiring emergency surgery, in which all Mplantationwas attempted in a 72-year-old gentleman with severe mitral regurgitation [1]. However, after clip closure it was impossible to detach the distal anchoring tip, and the whole system remained entrapped with the clip anchored to mitral leaflets. The procedure was thus converted to emergency surgery. After patient and entire delivery system mobilization to the operating room (Fig 1), standard median sternotomy and bicaval cannulation were performed. The exposure was challenging due to the
International Journal of Case Reports in Medicine | 2014
Antonio Barretta; Antonino G.M. Marullo; Mariangela Peruzzi; Giuseppe Mazzesi; Piero Proietti; Ernesto Greco; David Rose; Ilaria Chirichilli; Chiara Santo; Giacomo Frati
We report the case of a 60-year-old man undergone an aortic valve replacement with a SmeloffCutter prosthesis 40 years ago. The patient underwent a redo aortic valve and ascending aorta replacement for ascending aorta aneurysm that intraoperatively appeared as a chronic Type A aortic dissection. The Smeloff-Cutter prosthesis looked intact and functionally normal. The ascending portion of the aorta appeared dissected two centimeters above the sino-tubular junction, between the non-coronary and the left coronary valsalva sinuses: we speculate that Smeloff-Cutter prosthesis may contribute, due to its rheology and features, to the determinism of aortic dilatation and subsequently dissection.
Journal of Interventional Cardiac Electrophysiology | 2009
Pietro Rossi; Stefano Bianchi; Antonio Barretta; Alberto Della Scala; Lilian Kornet; Ruggero De Paulis; Alessandro Bellisario; Vittorio D’Addio; Herribert Pavaci; Fabio Miraldi
European Journal of Cardio-Thoracic Surgery | 2007
Fabio Miraldi; Chiara Taffon; Michele Toscano; Antonio Barretta
Texas Heart Institute Journal | 2004
Vito Paolillo; Daniela Gastaldo; Antonio Barretta; Francisco Guerra
Texas Heart Institute Journal | 2007
Luigi Muzzi; Federico Bizzarri; Antonio Barretta; Fabio Miraldi; Andrea Laghi; Giuseppe Pugliese; Patrizio Sartini; Giacomo Frati
Enliven: Journal of Anesthesiology and Critical Care Medicine | 2015
Mariangela Peruzzi; Giuseppe Biondi-Zoccai; Antonino G.M. Marullo; Antonio Barretta; Sara Izzo; Piergiusto Vitulli; and Giacomo Frati
Enliven: Journal of Anesthesiology and Critical Care Medicine | 2015
Mariangela Peruzzi; Giuseppe Biondi-Zoccai; Ernesto Greco; Antonino G.M. Marullo; Antonio Barretta; Piergiusto Vitulli; Giulio Pompilio; and Giacomo Frati